Pancreatic cancer: Early detection with one drop of urine: Cancer test N-NOSE
-Finally the long-standing dream of the medical world-
Medical venture company
HIROTSU Bioscience
November 16th
Just take a drop of urine
Early pancreatic cancer that is difficult to detect,
Announced that it has become possible to identify.
It is scheduled to be put into practical use in 2022.
Identify early pancreatic cancer:
HIROTSU Bioscience utilizes the sense of smell of nematodes living in the soil.
Smell of urine in cancer patients
Nematodes are attracted to the smell of urine containing cancer components.
The smell of urine from healthy people
Nematodes have the property of escaping from the odor of urine of healthy people.
Taking advantage of this property, we have developed and put into practical use the cancer screening N-NOSE.
Started commercialization of inspection:
Inspection and practical application started in 2020.
Opened inspection reception bases “N-NOSE Stations” in various parts of Japan such as Tokyo and Osaka.
“N-NOSE Station”:
We are currently accepting samples.
With one drop of urine, the risk of cancer throughout the body can be determined with high accuracy.
Since the cost of raising nematodes is low, the inspection fee is also low.
Genetic modification technology:
Until now, it was not possible to identify the type of cancer.
this time,
“Special nematodes that show a special reaction only to the smell of pancreatic cancer” using genetic recombination technology
I succeeded in developing it.
President Takaaki Hirotsu:
Pancreatic cancer, which is said to be the most difficult to detect early.
He said he rushed to develop a specific test for pancreatic cancer ahead of other cancer types.
Mysterious news